DE3788226D1 - System und verfahren zur transkutanen fruchtbarkeitskontrolle. - Google Patents

System und verfahren zur transkutanen fruchtbarkeitskontrolle.

Info

Publication number
DE3788226D1
DE3788226D1 DE87905994T DE3788226T DE3788226D1 DE 3788226 D1 DE3788226 D1 DE 3788226D1 DE 87905994 T DE87905994 T DE 87905994T DE 3788226 T DE3788226 T DE 3788226T DE 3788226 D1 DE3788226 D1 DE 3788226D1
Authority
DE
Germany
Prior art keywords
transcutaneous
fertility control
fertility
control
transcutaneous fertility
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE87905994T
Other languages
English (en)
Other versions
DE3788226T2 (de
Inventor
Yie Chien
Te-Yen Chien
Yih-Chain Huang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rutgers State University of New Jersey
Original Assignee
Rutgers State University of New Jersey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rutgers State University of New Jersey filed Critical Rutgers State University of New Jersey
Application granted granted Critical
Publication of DE3788226D1 publication Critical patent/DE3788226D1/de
Publication of DE3788226T2 publication Critical patent/DE3788226T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Eye Examination Apparatus (AREA)
DE87905994T 1986-08-29 1987-08-28 System und verfahren zur transkutanen fruchtbarkeitskontrolle. Expired - Fee Related DE3788226T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/902,440 US4818540A (en) 1985-02-25 1986-08-29 Transdermal fertility control system and process
PCT/US1987/002142 WO1988001496A1 (en) 1986-08-29 1987-08-28 Transdermal fertility control system and process

Publications (2)

Publication Number Publication Date
DE3788226D1 true DE3788226D1 (de) 1993-12-23
DE3788226T2 DE3788226T2 (de) 1994-05-05

Family

ID=25415870

Family Applications (1)

Application Number Title Priority Date Filing Date
DE87905994T Expired - Fee Related DE3788226T2 (de) 1986-08-29 1987-08-28 System und verfahren zur transkutanen fruchtbarkeitskontrolle.

Country Status (10)

Country Link
US (1) US4818540A (de)
EP (1) EP0328524B1 (de)
JP (1) JP2573638B2 (de)
KR (1) KR950008164B1 (de)
AU (2) AU621034B2 (de)
CA (1) CA1310268C (de)
DE (1) DE3788226T2 (de)
DK (1) DK231588A (de)
FI (1) FI890945A (de)
WO (1) WO1988001496A1 (de)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296230A (en) * 1985-02-25 1994-03-22 Rutgers, The State University Of New Jersey Transdermal fertility control system and process
US5560922A (en) * 1986-05-30 1996-10-01 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process
US5145682A (en) * 1986-05-30 1992-09-08 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
AU607172B2 (en) * 1986-12-22 1991-02-28 Cygnus, Inc. Diffusion matrix for transdermal drug administration
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
US5256421A (en) * 1987-09-24 1993-10-26 Jencap Research Ltd. Hormone preparation and method
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US4994278A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Breathable backing
DE3823070A1 (de) * 1988-07-07 1990-02-22 Kettelhack Riker Pharma Gmbh Selbstklebendes heftpflaster
CA2000401C (en) * 1988-10-11 1996-05-28 Masato Azuma Percutaneous pharmaceutical preparation
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5059426A (en) * 1989-03-22 1991-10-22 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
US4973468A (en) * 1989-03-22 1990-11-27 Cygnus Research Corporation Skin permeation enhancer compositions
US5053227A (en) * 1989-03-22 1991-10-01 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
US5252334A (en) * 1989-09-08 1993-10-12 Cygnus Therapeutic Systems Solid matrix system for transdermal drug delivery
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
US5096715A (en) * 1989-11-20 1992-03-17 Alko Ltd. Method and means for treating alcoholism by extinguishing the alcohol-drinking response using a transdermally administered opiate antagonist
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
US5158978A (en) * 1990-02-05 1992-10-27 British Technology Group (U.S.A.) Thyroid hormone treatment of acute cardiovascular compromise
DK0754456T3 (da) * 1990-06-01 2002-11-11 Population Council Inc Forberedelse af sammensætninger der omfatter ST1435 til topisk anvendelse
US5627035A (en) * 1990-08-22 1997-05-06 Syntello Vaccine Development Ab Peptides that block human immunodeficiency virus and methods of use thereof
IT1243745B (it) * 1990-10-17 1994-06-21 Vectorpharma Int Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione.
US5320850A (en) * 1990-10-29 1994-06-14 Alza Corporation Transdermal delivery of the gestogen ST-1435 and devices therefor
MX9101787A (es) * 1990-10-29 1992-06-05 Alza Corp Formulaciones,metodos y dispositivos anticonceptivos transdermicos
US5198223A (en) * 1990-10-29 1993-03-30 Alza Corporation Transdermal formulations, methods and devices
US5518734A (en) * 1991-09-25 1996-05-21 Beta Pharmaceuticals Co. Transdermal delivery system for estradiol and process for manufacturing said device
US5705185A (en) * 1991-09-25 1998-01-06 Beta Pharmaceuticals Co. Transdermal delivery of estradiol and process for manufacturing said device
JP2960832B2 (ja) * 1992-05-08 1999-10-12 ペルマテック テクノロジー アクチェンゲゼルシャフト エストラジオールの投与システム
DE4309830C1 (de) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Wirkstoffpflaster für die Abgabe von Estradiol an die Haut
US5759548A (en) * 1993-11-30 1998-06-02 Lxr Biotechnology Inc. Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
AU692504B2 (en) * 1993-12-27 1998-06-11 Akzo Nobel N.V. Percutaneously absorbable preparation
NZ293849A (en) * 1994-09-14 1998-10-28 Minnesota Mining & Mfg Transdermal delivery matrix comprising a macromonomer containing acrylate or metacrylate copolymer, a softener and a drug
IL122432A (en) * 1995-06-07 2000-07-16 Cygnus Therapeutic Systems Transdermal patch for preventing ovulation
US5785991A (en) * 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US6063757A (en) * 1995-11-29 2000-05-16 Urso; Richard G. Wound treatment method with nerve growth factor
US5762956A (en) * 1996-04-24 1998-06-09 Rutgers, The State University Of New Jersey Transdermal contraceptive delivery system and process
US6495532B1 (en) * 1997-03-19 2002-12-17 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
US6949528B1 (en) 1998-03-18 2005-09-27 Goddard John G Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
US6190699B1 (en) 1998-05-08 2001-02-20 Nzl Corporation Method of incorporating proteins or peptides into a matrix and administration thereof through mucosa
US6818612B2 (en) 1998-11-24 2004-11-16 Kristina Broliden Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
US6743772B1 (en) 1998-11-24 2004-06-01 Kristina Broliden Use of parovirus capsid particles in the inhibition of cell proliferation and migration
US6153850A (en) 1999-04-29 2000-11-28 The Esab Group, Inc. Method of cutting a workpiece along an arcuate path with a plasma arc torch
US6680176B2 (en) 1999-05-17 2004-01-20 The United States Of America, As Represented By The Department Of Health And Human Services Identification of candidate ligands which modulate antigen presenting cells
CA2374930C (en) 1999-07-02 2008-08-05 Lts Lohmann Therapie-Systeme Ag Microreservoir system based on polysiloxanes and ambiphilic solvents
US6258932B1 (en) 1999-08-09 2001-07-10 Tripep Ab Peptides that block viral infectivity and methods of use thereof
US7384650B2 (en) * 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
DE10003767A1 (de) * 2000-01-28 2001-10-04 Beiersdorf Ag Hautfreundliches Wirkstoffpflaster zur transdermalen Verabreichung nichtsteroidaler Antirheumatika
US20060063738A1 (en) * 2000-02-28 2006-03-23 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
JP2001240236A (ja) 2000-03-01 2001-09-04 Shikoku Kakoki Co Ltd コンベヤ
US7022830B2 (en) * 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US6680059B2 (en) * 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
ES2296803T3 (es) 2000-08-17 2008-05-01 Tripep Ab Vacunas que contienen ribavirina.
RU2286172C2 (ru) * 2000-08-17 2006-10-27 Трипеп Аб Вакцины, содержащие рибавирин, и способы их использования
US7011965B2 (en) 2001-03-09 2006-03-14 Regents Of The University Of Minnesota Compositions and methods for stimulating wound healing and fibroblast proliferation
WO2003024995A1 (en) * 2001-09-19 2003-03-27 Tripep Ab Molecules that block viral infectivity and methods of use thereof
US20040067512A1 (en) * 2001-11-09 2004-04-08 Neurogenetics, Inc. Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
AU2002364894A1 (en) * 2001-11-09 2003-06-30 Neurogenetics, Inc. Single nucleotide polymorphisms and mutations on alpha-2-macroglobulin
DE20217814U1 (de) * 2002-11-18 2004-04-08 Asat Ag Applied Science & Technology Melatonin-Tagesdosierungseinheiten
KR100849916B1 (ko) * 2002-10-30 2008-08-04 아에스아테 아게 어플라이드 사이언스 앤드 테크놀로지 멜라토닌 일일 투여 유닛
US7048914B2 (en) * 2002-12-12 2006-05-23 Zoltan Laboratories Placental alkaline phosphatase to control diabetes
KR20050099536A (ko) 2003-02-06 2005-10-13 트리펩 아베 글리코실화된 특이성 교환체
US20050096319A1 (en) * 2003-02-21 2005-05-05 Balzarini Jan M.R. Identification of compounds that inhibit replication of human immunodeficiency virus
JP2006518373A (ja) * 2003-02-21 2006-08-10 トリペップ アクチ ボラゲット Ｈｉｖ複製を抑制するためのグリシンアミド誘導体
US7374754B2 (en) * 2003-09-02 2008-05-20 Essential Skincare, Llc Use of placental alkaline phosphatase to promote skin cell proliferation
CA2573392A1 (en) * 2004-07-12 2006-09-08 Rappaport Family Institute For Research In The Medical Sciences Methods of detecting a phenotype of a polymorphic protein
ATE514708T1 (de) 2004-08-27 2011-07-15 Chrontech Pharma Ab Transgene mausmodelle des hepatitis c virus (hcv) sowie identifizierung von hcv therapeutika
WO2007031867A2 (en) 2005-05-25 2007-03-22 Tripep Ab A hepatitis c virus non-stru tural ns3/4a fusion gene
WO2007032818A2 (en) * 2005-09-12 2007-03-22 Zoltan Laboratories Llc Compounds and compositions to control abnormal cell growth
EP1965830B1 (de) * 2005-12-28 2014-05-14 Zoltan Laboratories Llc Verwendung von alkalischer phosphatase zur erhaltung von gesunder gewebemasse bei säugetieren
US7718170B2 (en) * 2006-08-21 2010-05-18 Essential Skincare, Llc Alkaline phosphatase compositions to reduce skin cancer
US8383589B2 (en) * 2007-07-09 2013-02-26 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Aegyptin and uses thereof
EP2185195A2 (de) 2007-08-16 2010-05-19 Tripep Ab Immunogen-plattform
WO2009130588A2 (en) * 2008-04-22 2009-10-29 Tripep Ab Immunogen platform
DE102009056745A1 (de) * 2009-12-04 2011-06-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für die Verabreichung von Peptiden
JP6180930B2 (ja) 2010-06-16 2017-08-16 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 創傷治癒過程における再上皮化を刺激するための方法及び組成物
WO2020239623A1 (en) 2019-05-24 2020-12-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of ngal inhibitors for the treating chronic wound

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US4336243A (en) * 1980-08-11 1982-06-22 G. D. Searle & Co. Transdermal nitroglycerin pad
DK243084A (da) * 1983-05-26 1984-11-27 Takeda Chemical Industries Ltd Perkutane farmaceutiske praeparater til udvortes brug
US4687481A (en) * 1984-10-01 1987-08-18 Biotek, Inc. Transdermal drug delivery system
US4624665A (en) * 1984-10-01 1986-11-25 Biotek, Inc. Method of transdermal drug delivery
ATE77962T1 (de) * 1985-02-25 1992-07-15 Univ Rutgers Dosierungssystem fuer transdermale absorption von arzneimittelwirkstoffen.
US4615699A (en) * 1985-05-03 1986-10-07 Alza Corporation Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes
AU601528B2 (en) * 1986-12-22 1990-09-13 Ortho-Mcneil Pharmaceutical, Inc. Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers

Also Published As

Publication number Publication date
AU621034B2 (en) 1992-03-05
JP2573638B2 (ja) 1997-01-22
CA1310268C (en) 1992-11-17
EP0328524B1 (de) 1993-11-18
DK231588A (da) 1988-06-14
US4818540A (en) 1989-04-04
KR950008164B1 (ko) 1995-07-26
DE3788226T2 (de) 1994-05-05
AU659457B2 (en) 1995-05-18
AU7916287A (en) 1988-03-24
WO1988001496A1 (en) 1988-03-10
EP0328524A4 (de) 1990-02-22
FI890945A0 (fi) 1989-02-28
DK231588D0 (da) 1988-04-28
EP0328524A1 (de) 1989-08-23
KR880701535A (ko) 1988-11-03
FI890945A (fi) 1989-02-28
AU1738092A (en) 1992-07-30
JPH02500740A (ja) 1990-03-15

Similar Documents

Publication Publication Date Title
DE3788226T2 (de) System und verfahren zur transkutanen fruchtbarkeitskontrolle.
DE3786977D1 (de) Systeme und verfahren zur prozessregelung.
DE3789650D1 (de) Verfahren und System zur Festkörpermodellierung.
DE3787921D1 (de) Ringnetzsystem und Verfahren zur Konfigurationssteuerung.
DE3776056D1 (de) Verfahren und vorrichtung zur daempfungsregelung.
DE3689533D1 (de) Plasmaphoresesystem und verfahren.
DE3866953D1 (de) Verfahren und system zur paketflusssteuerung.
DE3869207D1 (de) System und verfahren zur paketflusssteuerung.
DE3880695D1 (de) System und verfahren zur persoenlichen identifizierung.
DE3682202D1 (de) Verfahren und vorrichtung zur uebertragung von informationssignalen.
DE3782801D1 (de) Verfahren zur schlagfeld-freund-feind-kennung und system zum ausfuehren davon.
DE3751391D1 (de) Verfahren und Vorrichtung zur Speichersteuerung.
DE3750070T2 (de) Verfahren und empfangsgerät zur null-reduktion.
DE3789864D1 (de) Verfahren und system zur radar angepassten datenübertragung.
DE3851534T2 (de) Vorrichtung und verfahren zur buszugriffssteuerung.
DE3852923T2 (de) Verfahren und System zur sequenziellen Steuerung.
DE3688718T2 (de) Verfahren und System zur gleichmässigen Verschiebung.
DE3688534T2 (de) Verfahren und Gerät zur Kultivierungssteuerung.
DE3578751D1 (de) Verfahren und system zur regelung von flugzeugbremsen.
DE3583223D1 (de) Verfahren und system zur regelung von flugzeugbremsen.
DE3853253T2 (de) Verfahren und System zur Sequenzsteuerung.
DE3780335D1 (de) Prozesssteuerungssystem und -verfahren.
DE3775383D1 (de) System und verfahren zur datenubertragung.
DE3784238T2 (de) Verfahren und einrichtung zur gestaltung von kabelbaeumen.
DE3785869T2 (de) System und Verfahren zur Prüfung menschlicher Faktoren.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee